Available from . 3. Leiderman DB. Risk management of drug products and the U.S. Food and Drug Administration: evolution and context. Drug Alcohol Depend 2009; 105 (suppl 1): S9-S13. 4. US Food and Drug Administration. Guidance for industry. Format and content of proposed risk evaluation and mitigation strategies (REMS), REMS assessments, and proposed REMS modifications. Silver Spring: US Food and Drug Administration; 2009. Available from . 5. American Pharmacists Association. White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system. J Am Pharm Assoc (2003) 2009; 49: 729-43. 6. US Food and Drug Administration. Approved risk evaluation and mitigation strategies (REMS). Silver Spring: US Food and Drug Administration; 2010. Available from . 7. US Food and Drug Administration. Identification of drug and biological products deemed to have Risk Evaluation and Mitigation Strategies for purposes of the Food and Drug Administration Act of 2007.